EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risks of prostate cancer and mortality in the city of Sharjah, United Arab Emirates

Zainab Al Shareef, Rula Al-Shahrabi, Fatemeh Saheb Sharif-Askari, Younis Alshamsi, Abdulqadir Al Zarooni, Noura AlKhayyal, Sameh S M Soliman, Riyad Bendardaf, Rabih Halwani

Frontiers in Oncology · 23.05.2023 · 13

DOI: 10.3389/fonc.2023.1180902 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 23.05.2023. Verfasst von Zainab Al Shareef und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostatic hyperplasia (BPH) and prostate cancer (PCa) are common age-related diseases in men. According to World Health Organization (WHO), PCa is the second most common cancer among Emirati men. This study aimed to identify the risk factors associated with PCa and mortality in a cohort diagnosed with PCa between 2012 and 2021 in Sharjah, United Arab Emirates (UAE).

Methods

The data collected in this retrospective case-control study included patient demographics and comorbidities, as well as PCa markers such as prostate-specific antigen (PSA), prostate volume, prostate-specific antigen density (PSAD), and Gleason scores. Risk factors for PCa were assessed using multivariate logistic regression analysis, and factors associated with all-cause mortality in PCa patients were evaluated using Cox-proportional hazard analysis.

Results

Of the 192 cases analyzed in this study, 88 were diagnosed with PCa and 104 were diagnosed with BPH. Regarding risk factors for PCa, a higher risk of PCa was associated with age 65 or older (OR=2.76, 95% confidence interval (CI): 1.04-7.30; P=0.038) and serum PSAD greater than 0.1 ng/mL 2 (OR=3.48, 95% CI:1.66-7.32; P=0.001), whereas being of UAE nationals (OR=0.40, 95% CI:0.18-0.88; P=0.029) were associated with lower risk of PCa, after adjusting for patient demographics and comorbidities. Moreover, regarding cancer markers, higher serum PSA level (P=0.003) and smaller prostate volume (P=0.028) were associated with a higher risk of PCa, after adjusting with patients’ age and BMI. Additionally, a high-grade Gleason score was associated with an increased risk of all-cause mortality after adjusting for patient’s age and BMI (hazard ratio, aHR= 2.3, 95% CI:1.3-4.1; P= 0.016).

Conclusion

This study found that age 65 or older and serum PSAD greater than 0.1 ng/mL 2 are risk factors for PCa, while UAE nationality is associated with a lower risk. PSAD may be a better screening marker for PCa compared to traditional markers such as PSA and prostate volume.

Schlagwörter

Stichwörter der Autor:innen

Gleason scorePSADall-cause mortalitybenign prostatic hyperplasiaprostate cancerrisk factors

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
  • Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
  • Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.
  • Urology Department, Al Qassimi Hospital, Sharjah, United Arab Emirates.
  • Urology Department, Shaikh Khalifa General Hospital, Umm Al Quwain, United Arab Emirates.
  • Oncology Unit, University Hospital of Sharjah, Sharjah, United Arab Emirates.

Zitieren

APA

Al Shareef, Z., Al-Shahrabi, R., Saheb Sharif-Askari, F., Alshamsi, Y., Zarooni, A. A., AlKhayyal, N., Soliman, S. S. M., Bendardaf, R., & Halwani, R. (2023). Risks of prostate cancer and mortality in the city of Sharjah, United Arab Emirates. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1180902

Vancouver

Al Shareef Z, Al-Shahrabi R, Saheb Sharif-Askari F, Alshamsi Y, Zarooni AA, AlKhayyal N, et al. Risks of prostate cancer and mortality in the city of Sharjah, United Arab Emirates. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1180902

BibTeX
@article{AlShareef2023,
  author = {Al Shareef, Zainab and Al-Shahrabi, Rula and Saheb Sharif-Askari, Fatemeh and Alshamsi, Younis and Zarooni, Abdulqadir Al and AlKhayyal, Noura and Soliman, Sameh S M and Bendardaf, Riyad and Halwani, Rabih},
  title = {Risks of prostate cancer and mortality in the city of Sharjah, United Arab Emirates},
  journal = {Frontiers in Oncology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fonc.2023.1180902}
}
Kostenlos starten →